$19.04
-2.8%National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
Chief Accounting Officer
Chief Corporate Development Officer
Chief Delivery Officer
Chief Experience Officer
Chief Operating Officer
Compensation
$407,886
Chief Product Officer
Founder, Chief Executive Officer, President, Principal Financial Officer & Director
Compensation
$129,862
Senior Manager of Content Marketing
During the last 12 months, insiders have purchased $896K worth of NRC shares, with no selling activity reported.
0
0.00
0
0.00
+0
+$0
8.0K
98.16K
0
0.00
+98K
+$98K
67.9K
788.03K
0
0.00
+788K
+$788K
771
10.00K
0
0.00
+10K
+$10K
Wheeler Penny Ann
Director
$263K
Berwick Donald M
Director
$263K
Nunnelly John N
Director
$263K
Harrison Shane R
Officer: Evp & Chief Financial Officer
$98K
Freeman Jordan Nicole
Officer: Chief Accounting Officer
$10K
No selling activity
Strong bullish signal with $896K net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Perfect buy/sell ratio. Only buying activity with zero selling—the most bullish possible insider signal.
5 insider buyers vs. 0 sellers. Broad-based buying across management team suggests widespread confidence.
Compelling insider conviction: The combination of strong buy/sell ratio and multiple buyers suggests insiders see attractive risk/reward. Consider this alongside fundamental analysis for confirmation.
NRC - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | May 08, 2026 | June 23, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 10, 2025 | May 07, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 11, 2024 | May 08, 2024 | 2024 | |
DEF 14A DEF 14A N/A | April 06, 2023 | April 06, 2023 | ||
DEF 14A DEF 14A 2022 N/A | April 07, 2022 | May 18, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | June 03, 2021 | June 29, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | April 07, 2020 | May 18, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | April 09, 2019 | May 29, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | April 27, 2018 | May 30, 2018 | 2018 | |
DEF 14A DEF 14A 2018 N/A | March 13, 2018 | April 16, 2018 | 2018 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.